The impact of the treatment of benign prostatic hyperplasia with lower urinary tract symptoms on quality of life, a scoping literature review aided by AI

被引:0
|
作者
Faraon, Bjarne [1 ,2 ]
Garces, Juan [1 ]
Ahmad, Sulaiman [1 ]
Mahmoud, Satanay [1 ]
Danzinger, Marc [1 ,2 ]
Shabsigh, Ridwan [1 ,2 ,3 ]
Mikelinich, Erik [4 ]
Carpo, Bea [4 ]
机构
[1] SBH Hlth Syst, Dept Surg, Bronx, NY 10457 USA
[2] CUNY, Sch Med, New York, NY 10031 USA
[3] Cornell Univ, Weill Cornell Med Coll, New York, NY 10065 USA
[4] NYIT Coll Osteopath Med, Glen Head, NY 11545 USA
关键词
Benign prostatic hyperplasia; Lower urinary tract symptoms; Quality of life; Intervention; TRANSURETHRAL RESECTION; PROSPECTIVE CROSSOVER; MANAGEMENT; EFFICACY; THERAPY; LASER; MEN;
D O I
10.22514/jomh.2024.104
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Benign prostatic hyperplasia (BPH) refers to a non-cancerous condition characterized by hyperplastic changes in stromal and epithelial cells. BPH can cause lower urinary tract symptoms (LUTS) that decrease quality of life (QoL). The International Prostate Symptom Score (IPSS) is a validated tool used to assess and guide the management of LUTS. This scoping review evaluated the difference in IPSS and QoL in patients with BPH and LUTS before and after medical or interventional treatment. A PubMed search was conducted using: (Benign prostatic hyperplasia OR lower urinary tract symptoms) AND (erectile dysfunction OR depression OR disability-adjusted life year OR quality of life), which yielded 7143 results over 10 years. With the use of artificial intelligence (AI), 31 articles were included in the study. Randomized control trials, prospective clinical trials, prospective and retrospective cohort studies, and meta-analyses were included. IPSS and IPSS-QoL measurements before and after intervention were required. Data was assessed in three categories "overall", "medical" and "interventional". Mean age, IPSS and QoL scores before and after intervention were calculated, as well as the Pearson correlation between baseline IPSS and QoL. Thirteen articles were categorized as medical while 18 were categorized as interventional. Pearson correlation between IPSS and QoL for overall, medical and interventional articles were r = 0.72, 0.79 and 0.36, respectively. There was an improvement in the QoL score by 1.28 points, 1.40 points, 2.49 points for overall, medical, and interventional groups, respectively. This study quantified the improvement in QoL after medical and interventional treatment of BPH. There is a strong correlation between the severity of BPH symptoms and the reduction of QoL. Improvement of BPH symptoms with medical and surgical treatments is associated with significant improvement in QoL.
引用
收藏
页码:8 / 14
页数:7
相关论文
共 50 条
  • [1] Sexual impact of treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia
    Wiser H.J.
    Köhler T.S.
    Current Urology Reports, 2010, 11 (4) : 228 - 235
  • [2] Impact of surgical treatment of benign prostate hyperplasia on lower urinary tract symptoms and quality of life
    Babic, Uros
    Soldatovic, Ivan
    Vukovic, Ivan
    Dragicevic, Svetomir
    Djordjevic, Dejan
    Acimovic, Miodrag
    Santric, Veljko
    Dzamic, Zoran
    Vuksanovic, Aleksandar
    VOJNOSANITETSKI PREGLED, 2019, 76 (01) : 30 - 35
  • [3] A Review of Naftopidil for Treatment of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia
    Fukuta F.
    Masumori N.
    Current Bladder Dysfunction Reports, 2015, 10 (2) : 160 - 169
  • [4] Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
    Sarma, Aruna V.
    Wei, John T.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (03): : 248 - 257
  • [5] Treatment of Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia Foreword
    Taneja, Samir S.
    UROLOGIC CLINICS OF NORTH AMERICA, 2016, 43 (03) : XIII - XIV
  • [6] Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function
    Miner, M
    Rosenberg, MT
    Perelman, MA
    CLINICAL THERAPEUTICS, 2006, 28 (01) : 13 - 25
  • [7] IMPACT OF TREATMENTS FOR LOWER URINARY TRACT SYMPTOMS/BENIGN PROSTATIC HYPERPLASIA ON EJACULATION
    Drasa, K.
    Dani, E.
    JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 251 - 251
  • [8] Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia, and Urinary Retention
    Alawamlh, Omar Al Hussein
    Goueli, Ramy
    Lee, Richard K.
    MEDICAL CLINICS OF NORTH AMERICA, 2018, 102 (02) : 301 - +
  • [9] Botulinum A toxin for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms
    Thomas C.A.
    Chuang Y.-C.
    Giannantoni A.
    Chancellor M.B.
    Current Urology Reports, 2006, 7 (4) : 266 - 271
  • [10] Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
    Garimella, Pranav S.
    Fink, Howard A.
    MacDonald, Roderick
    Wilt, Timothy J.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2009, (04):